NCT06872450

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2025

Completed
Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

February 25, 2025

Last Update Submit

August 7, 2025

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

informational and motivational tool

Outcome Measures

Primary Outcomes (3)

  • motivational effectiveness

    Motivation to stop smoking (QMAT test)

    60 days

  • motivational effectiveness

    Anxio-depressive state (HAD scale)

    60 days

  • motivational effectiveness

    Degree of dependence (Fagerström test)

    60 days

Study Arms (1)

informational intervention

informational intervention

Other: informational intervention

Interventions

informational interventionOTHER

informational intervention

informational intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3

You may qualify if:

  • People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
  • People treated at HNFC
  • Smokers

You may not qualify if:

  • People with cognitive disorders compromising comprehension and completion of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Nord Franche-comté

Trévenans, 90400, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 12, 2025

Study Start

February 14, 2025

Primary Completion

May 9, 2025

Study Completion

May 9, 2025

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)